Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 12, 2016
Grant Date -
Mar 19, 2015
app pub date -
Aug 5, 2013
filing date -
Aug 3, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully